Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mueller-Brand

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 26, 1998
Ectopic hematopoietic bone marrow in the appendicular skeleton after traumaA Kaim, P Ochsner, T Maurer, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 15, 2000
Exceptional results in neuroendocrine-metastases-caused paraplegia treated with [90Y-DOTA]-D-Phe1-Tyr3-octreotide (90Y-DOTATOC), a radiolabelled somatostatin analogueC Waldherr, A Haldemann, H R Maecke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2001
The clinical value of [90Y-DOTA]-D-Phe1-Tyr3-octreotide (90Y-DOTATOC) in the treatment of neuroendocrine tumours: a clinical phase II studyC Waldherr, M Pless, H R Maecke, et al.
Neurological Research|March 1, 1990
Cerebral blood flow and common carotid flow in neurologically asymptomatic carotid endarterectomy patientsO Gratzl, J Rem, H R Mueller, et al.
Oncology|May 13, 2004
Successful targeted radiotherapy with 90Y-DOTATOC in a patient with Merkel cell carcinoma. A Case ReportG Meier, C Waldherr, R Herrmann, et al.
European Journal of Nuclear Medicine|July 1, 1997
Chronic complicated osteomyelitis of the appendicular skeleton: diagnosis with technetium-99m labelled monoclonal antigranulocyte antibody-immunoscintigraphyA Kaim, T Maurer, P Ochsner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1997
Functional brain imaging in 200 patients after whiplash injuryA Otte, J Mueller-Brand, E U Nitzsche, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|January 30, 2013
Is there need for radioimmunotherapy? results of a phase I/II study in patients with indolent B-cell lymphomas using lutetium-177-DOTA-rituximabF Forrer, C Oechslin-Oberholzer, B Campana, et al.
Lancet (London, England)|March 3, 1998
Yttrium-90-labelled somatostatin-analogue for cancer treatmentA Otte, J Mueller-Brand, S Dellas, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 16, 2004
A comparison of (111)In-DOTATOC and (111)In-DOTATATE: biodistribution and dosimetry in the same patients with metastatic neuroendocrine tumoursF Forrer, H Uusijärvi, C Waldherr, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 26, 1998
Ectopic hematopoietic bone marrow in the appendicular skeleton after traumaA Kaim, P Ochsner, T Maurer, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 15, 2000
Exceptional results in neuroendocrine-metastases-caused paraplegia treated with [90Y-DOTA]-D-Phe1-Tyr3-octreotide (90Y-DOTATOC), a radiolabelled somatostatin analogueC Waldherr, A Haldemann, H R Maecke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2001
The clinical value of [90Y-DOTA]-D-Phe1-Tyr3-octreotide (90Y-DOTATOC) in the treatment of neuroendocrine tumours: a clinical phase II studyC Waldherr, M Pless, H R Maecke, et al.
Neurological Research|March 1, 1990
Cerebral blood flow and common carotid flow in neurologically asymptomatic carotid endarterectomy patientsO Gratzl, J Rem, H R Mueller, et al.
Oncology|May 13, 2004
Successful targeted radiotherapy with 90Y-DOTATOC in a patient with Merkel cell carcinoma. A Case ReportG Meier, C Waldherr, R Herrmann, et al.
European Journal of Nuclear Medicine|July 1, 1997
Chronic complicated osteomyelitis of the appendicular skeleton: diagnosis with technetium-99m labelled monoclonal antigranulocyte antibody-immunoscintigraphyA Kaim, T Maurer, P Ochsner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1997
Functional brain imaging in 200 patients after whiplash injuryA Otte, J Mueller-Brand, E U Nitzsche, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|January 30, 2013
Is there need for radioimmunotherapy? results of a phase I/II study in patients with indolent B-cell lymphomas using lutetium-177-DOTA-rituximabF Forrer, C Oechslin-Oberholzer, B Campana, et al.
Lancet (London, England)|March 3, 1998
Yttrium-90-labelled somatostatin-analogue for cancer treatmentA Otte, J Mueller-Brand, S Dellas, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 16, 2004
A comparison of (111)In-DOTATOC and (111)In-DOTATATE: biodistribution and dosimetry in the same patients with metastatic neuroendocrine tumoursF Forrer, H Uusijärvi, C Waldherr, et al.
Pageof 4